Dr Ian Geh's Published Studies
List of Publications
Moran B, Karandikar S, Geh I. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Introduction. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13702. PMID: 28632314
Cunningham C, Leong K, Clark S, Plumb A, Taylor S, Geh I, Karandikar S, Moran B. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - diagnosis, investigations and screening. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13703. PMID: 28632312
Moran B, Cunningham C, Singh T, Sagar P, Bradbury J, Geh I, Karandikar S. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Surgical management. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13704. PMID: 28632309
Gollins S, Moran B, Adams R, Cunningham C, Bach S, Sun Myint A, Renehan A, Karandikar S, Goh V, Prezzi D, Langman G, Ahmedzai S, Geh I. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Multidisciplinary management. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13705. PMID: 28632307
Geh I, Gollins S, Renehan A, Scholefield J, Goh V, Prezzi D, Moran B, Bower M, Alfa-Wali M, Adams R. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Anal cancer. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13709. PMID: 28632308
Pasquale S, Yim G, Zohra RS, Mocellin S, Nyanhongo D, Marriott P, Geh JI, Griffiths EA. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable oesophageal carcinoma: a network analysis. Ann Surg 2017; 265: 481-91. PMID: 27429017
Crosby T, Hurt CN, Falk S, Gollins S, Staffurth J, Ray R, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G, Mukherjee S. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. Brit J Cancer 2017;Mar 14;116(6):709-716. doi: 10.1038/bjc.2017.21. PMID: 28196063
Yahya S, Heyes G, Nightingale P, Lamin S, Chanda S, Geh I, Spooner D, Cruickshank G, Sanghera P. Linear accelerator radiosurgery for arteriovenous malformations: updated literature review. J Clin Neurosurg 2017; 38: 91-5. PMID: 28117260
Edwards N, Nolan O, Pawade T, Oelofse T, Singh H, Mehrzad H, Zia Z, Geh JI, Ayuk J, Palmer D, Shah T, Rooney S, Steeds R. Effect of valvular surgery in carcinoid heart disease: an observational cohort study. J Clin Endocrin Metabolic Med 2016; 101: 183-90. PMID: 26580239
Smart CJ, Korsgen S, Hill J, Speake D, Levy B, Steward M, Geh JI, Robinson J, Sebag-Montefiore D, Bach SP. A multicentre cohort study of organ preservation for T1 and T2 rectal cancer using short course preoperative radiotherapy and TEMS. Br J Surg 2016; Jul; 103(8): 1069-75. PMID: 27146472
Morris E, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D. Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the English NHS. Clin Oncol 2016 28(8); 522-31. PMID: 26936609
Rees J, Hurt C, Gollins S, Mukherjee S, Maughan T, Falk SJ, Staffurth J, Ray R, Bashir N, Bridgewater J, Geh JI, Cunningham D, Roy R, Griffiths G, Nixon L, Blazeby JM, Crosby T. Patient reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Brit J Cancer 2015: 113: 603-10. PMID: 26203761
Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series. Benghiat H, Heyes G, Nightingale P, Hartley A, Tiffany M, Spooner D, Geh JI, Cruickshank G, Irving R, Sanghera P. Clin Oncol 2014; 26: 309-15. PMID: 24636634
Glynne-Jones R, Kadalayil L, Meadows H, Cunningham D, Samuel L, Geh I, Lowdell C, James R, Beare S, Begum R, Sebag-Montefiore D, on behalf of the ACT II study group. Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II. Ann Oncol 2014; 25: 1616-22. PMID: 24827136
Tiernan J, Cook A, Geh I, George B, Magill L, Northover J, Verjee A, Wheeler J, Fearnhead N. Use of modified Delphi approach to develop research priorities for the Association of Coloproctology of GB and Ireland. Colorectal Dis 2014; 16: 965-70. PMID: 25284641
Pettit L, Meade S, Sanghera P, Glaholm J, Geh JI, Hartley A. Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation? Br J Radiol 2013 Jan; 86 (1021). PMID: 23239699
Crosby T, Hurt C, Falk S, Gollins S, Mukherjee S, Staffurth J, Ray R, Bashir N, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G. A multicentre, phase II/III randomized trial of chemoradiotherapy in oesophageal caner plus or minus cetuximab - the SCOPE 1 trial. Lancet Oncology 2013; 14: 627-37. PMID: 23623280
.
Geh JI, Ma YT. Commentary: Evolution of systemic therapy for metastatic colorectal cancer. Colorectal Dis 2011; 13: 852-4. PMID: 21762349
Sinha V, Dyer P, Roy-Choudhury S, Geh JI, Karandikar S. A case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis. Eur J Gastroenterol Hepatol 2009; 21: 101-3. PMID: 19086149
Harris AR, Bowley DM, Stannard A, Kurrimboccus S, Geh JI, Karandiakr S. Socioeconomic deprivation adversely affects survival for patients with rectal cancer. Br J Surg 2009; 96: 763-8. PMID: 19526619
Sanghera P, Wong DWY, McConkey CC, Geh JI, Hartley A. Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol 2008; 20: 176-83. PMID: 18248971
Wong D, Lupton S, Zaman L, Peake D, Spooner D, Taniere P, Geh JI. Use of imatinib mesylate in gastrointestinal stromal tumours (GISTs): Pan-Birmingham Cancer Network experience. Clin Oncol 2008; 20: 517-22. PMID: 18514495
Henry AM, Ryder WDJ, Moore C, Sherlock DJ, Geh JI, Dunn P, Price P. Chemo-radiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study. Clin Oncol 2008; 20: 541-7. PMID: 18562186
Osman F, Geh JI, Griffith MJ. An unusual cause of cardiac paradox. Eur J Echocardiogr 2007; 8: 91-2. PMID: 16784896
Salmons N, Pallalau A, Gregg RJ, Woolhouse I, Tanière P, Geh JI. Lymphomatoid granulomatosis in a patient being treated for metastatic gastrointestinal stromal tumour with imatinib mesylate. J Clin Path 2007; 60: 199-201. PMID: 17264244
Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006; 78: 236-44. PMID: 16545878
Giridharan S, Vakkalanka B, Anwar MS, Geh JI, Glaholm J, Churn M, Adab F, Grieve R, McConkey C, Hartley A. Multicentre prospective audit of surgical outcomes and acute complications following short course preoperative radiotherapy for resectable rectal cancer. Colorectal Dis 2005; 7: 43-6. PMID: 15606583
Wilson D, Hiller L, Geh JI. Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clin Oncol 2005; 17: 81-90. PMID: 15830569
Ayuk J, Natarajan G, Geh JI, Mitchell RD, Gittoes NJL. Pituitary carcinoma with a single metastasis causing cervical spinal cord compression. J Neurosurg 2005; 2: 349-52. PMID: 15796362
Hartley A, Ho KF, McConkey C, Geh JI. An analysis of factors associated with pathological complete response of rectal adenocarcinoma following chemoradiotherapy in phase II/III trials. Br J Radiol 2005; 78: 934-8. PMID: 16177017
Clark MA, Hartley A, Geh JI. Anal canal cancer. Lancet Oncology 2004; 5: 149-57. PMID: 15003197
Wilson D, Hiller L, Geh JI. ECF in stomach cancer. Clin Oncol 2004; 16: 381-2 (letter). PMID: 15341448
Hussain SA, Stocken DD, Riley P, Palmer DH, Peake D, Geh JI, Spooner D, James ND. A phase I/II study of gemcitabine and fractionated cisplatin in an out-patient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer 2004; 91: 844-9. PMID: 15292922
Hartley A, Giridharan S, Srihari N, McConkey C, Geh JI. Impaired postoperative neutrophil leucocytosis and acute complications following short course preoperative radiotherapy for operable rectal cancer. Eur J Surg Oncol 2003; 29: 155-157. PMID: 12633558
King M, Tolan S, Giridharan S, McConkey C, Hartley A, Geh JI. Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer. Clin Oncol 2003; 15: 233-6. PMID: 12924451
Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-313. PMID: 11803146
Hartley A, Giridharan S, Gray L, Billingham L, Ismail T, Geh JI. Retrospective study of acute toxicity following short-course preoperative radiotherapy. Br J Surg 2002; 89: 889-95. PMID: 12081739
Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-56. PMID: 11260097
Geh JI, Glynne-Jones R, Kwok QSK, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC. Preoperative ECF chemotherapy for advanced gastro-oesophageal adenocarcinoma. Clin Oncol 2000; 12: 182-7. PMID: 10942336
Bygrave HA, Geh JI, Jani Y, Glynne-Jones R. Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature. Clin Oncol 1998; 10: 334-6. PMID: 9848338
Geh JI, Glynne-Jones R. Cervical spine metastases in colorectal carcinoma. Clin Oncol 1998; 10: 125-8. PMID: 9610902
Geh JI, Spittle MF. Oncological Problems in AIDS: a review of the clinical features and management. Ann Acad Med Singapore 1996; 25: 380-91. PMID: 8876905
Book Chapters
Khan Y, Radley S, Geh JI. Anal Cancer. In: Surgery of the anal canal. ECAB clinical update: Surgical Gastroenterology and liver transplantation. Ed: Karandikar S (2014).
Ford D, Geh JI. Oesophageal Cancers. In: Oxford Desk Reference: Oncology. Eds: Ajithkumar T, Cook N, Hatcher H, Barrett A. Oxford University Press, Oxford (2011).
Ford D, Walji N, Geh JI. Stomach Cancers. In: Oxford Desk Reference: Oncology. Eds: Ajithkumar T, Cook N, Hatcher H, Barrett A. Oxford University Press, Oxford (2011).
Chambers RJ, Geh I, Roy-Choudhury S. Oesophageal tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).
Miller B, Geh I, Roy-Choudhury S. Gastric tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).
Miller B, Geh I, Roy-Choudhury S. Hepatic and biliary tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).
Miller B, Geh I, Roy-Choudhury S. Pancreatic tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).
Mahon B, Seddon B, Geh I. Gastrointestinal stromal tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).
Anwar MS, Geh JI, Spooner D. The role of radiotherapy in upper gastrointestinal tumours. In: Upper Gastrointestinal Surgery. Eds: Fielding JWL, Hallissey MT. Springer Specialist Surgical Series (2005).
National Guidelines
Association of Coloproctology of Great Britain & Ireland. Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017).
Chair of Guideline Development Committee
Reid R, Bulusu R, Carroll N, Eatock M, Geh I, Judson I, O’Dwyer P, Warren B, Seddon B, Hill G. Guidelines for the management of gastrointestinal stromal tumours (GIST) 2009.
Member of Guideline Development Committee
Association of Coloproctology of Great Britain & Ireland. Guidelines for the Management of Colorectal (3rd Edition) 2007.
Member of Guideline Development Committee
Royal College of Radiologists Radiotherapy Dose-Fractionation: Gastro-Oesophageal Cancer. June 2006 (ISBN 1-905034-14-8).
Member of Guideline Development Committee
Bulusu R, Eatock, Carrol, Geh I, Hardwick R, Judson I, Roberts A, Reid R, Toh, S, Warren B. Management of patients with gastrointestinal stromal tumours (GISTs) 2004.
Member of Guideline Development Committee
List of Invited Lectures and Oral Presentations
Introduction and audit data
Royal College of Radiologists, MDT Management of Anal Cancer, Birmingham 18 Oct 2017
Defunctioning stomas
Royal College of Radiologists, MDT Management of Anal Cancer, Birmingham 18 Oct 2017
Chemoradiotherapy for early rectal cancer
SPECC Workshop, Good Hope Hospital, Sutton Coldfield, 13 May 2016
Neoadjuvant chemotherapy in colon and rectal cancer
6th International Colorectal Masterclass, Pelican Centre, Basingstoke, 7 April 2016
Neoadjuvant therapy - tailored for different diseases?
St Mark’s Hospital, London, 25 November 2015
Update on rectal cancer
37th National Conference of Association of Colon & Rectal Surgeons of India, Lucknow, India, 27 September 2014
Rectal cancer MDT case presentations
37th National Conference of Association of Colon & Rectal Surgeons of India, Lucknow, India, 27 September 2014
Management of colorectal adenocarcinoma in the presence of synchronous liver metastases - an oncologist’s perspective
LSSCN HPB Educational Meeting, Royal Blackburn Hospital, 17 July 2013
Multidisciplinary management of colorectal cancers (preoperative radiotherapy)
Pelican Centre, Basingstoke, 26 January 2012
Whats new in rectal cancer? The apparent complete response
Dukes’ Club Annual Meeting, Kenilworth, 25th February 2012
Management of GISTs
Association of Surgeons of GB and Ireland, Liverpool, 11 May 2012
Pattern and treatment of locoregional failure after definitive chemoradiotherapy for anal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Dublin, 3 July 2012
Rectal cancer - Not for the chop (co-chair of session and case presentations)
Association of Coloproctology of GB & Ireland Annual Meeting, Dublin, 3 July 2012
Management of oesophageal cancer
Annual Scientific Congress of Malaysian Oncologoical Society, Melacca, 8 September 2012
Update on colorectal cancer
Annual Scientific Congress of Malaysian Oncologoical Society, Melacca, 8 September 2012
Neoadjuvant therapy for lower third rectal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Birmingham, 22 June 2011
The long and short of radiotherapy in rectal cancer
Asia Pacific Cancer Conference, Kuala Lumpur, Malaysia, 11 November 2011
Multidisciplinary management of rectal cancer
Asia Pacific Cancer Conference, Kuala Lumpur, Malaysia, 11 November 2011
Mutations in GISTs and their implications for treatment (GIST Support UK)
GIST Support UK, Birmingham, 26 April 2010
Multidisciplinary management of colorectal cancers: low rectal cancers
Case presentations
Controversies in the use of radiotherapy in low rectal cancers
Association of Coloproctology of GB & Ireland Annual Meeting, Bournemouth, 29 June 2010
Neoadjuvant radiotherapy and organ conservation in early rectal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Bournemouth, 30 June 2010
Chemoradiation trials in pancreatic cancer: PACER, SCALOP and PERU
NCRI Upper GI Trials Annual Meeting, London, 15 October 2009
Debate: Should we routinely use short course preoperative radiotherapy in rectal cancer?
UK Coloectal Cancer Consensus Meeting 2008, London, 18 November 2008
The role of radiotherapy and chemotherapy in rectal cancer
BIR President’s Conference 2007: Developments in the Diagnosis and Treatment of Colorectal and Breast Cancer, 18 May 2007
Controversies of preoperative chemoradiotherapy in oesophageal cancer
Combined Chemotherapy & Radiotherapy in GI Tumours, British Institute of Radiology, London, 16 November 2007
Evidence base for short course preoperative radiotherapy
Royal Society of Medicine (Coloproctology & Oncology Sections), London, 24 February 2006
Radiotherapy planning workshop (lower GI cancer): The bottom line of anal cancer planning
British Institute of Radiology, London, 31 March 2006
Multimodality treatment of esophageal cancer
International Symposium on Progress in Esophageal Diseases, Mainz, Germany, 24 June 2006
How do The CR 07 results fit with other recent trials?
Association of Coloproctology of GB & Ireland 2006 Annual Meeting, Gateshead, 4 July 2006
The NCRI SCOPE-1 trial
NCRI Upper GI Trials Annual Meeting, London 6 July 2006
Whats new and emerging in 2006 in cancer medicine?
Masterclass in Advanced Cancer Medicine: Upper GI Cancer, London, 14 December 2006
If I had £1 million per year of new funding for my network, I would spend it on...
Cancer Agenda for 2005, New Hall, Sutton Coldfield, West Midlands, 4 February 2005
Gastrointestinal stromal tumours
Royal College of Radiologists Annual Meeting, London, 13 September 2005
The Role of the oncologist in managing rectal cancer
Royal Society of Medicine (Coloproctology Section), Leeds, 2 December 2005
Debate: This house believes that patients are entitled to receive cancer treatment of their choice on the NHS
Cancer Focus Seminars: Rare Cancers Training Day, 27 April 2004
What’s new in the non-surgical management of rectal cancer
Association of Coloproctology of Great Britain & Ireland Annual Meeting, Birmingham, 29 June 2004
Neoadjuvant treatment of oesophageal cancer: patient selection, evaluation of response & results
14th World Congress of the International Association of Surgeons & Gastroenterologists (IASG), 9-12 September 2004
Debate: This house believes that patients are entitled to receive cancer treatment of their choice on the NHS
British Oncology Pharmacists’ Association (BOPA) Annual Meeting, Birmingham, 9 October 2004
Controversies in cancer care: upper GI cancer
British Oncological Association Annual Meeting, Manchester, 12 September 2003
NHS Cancer Plan: is it making a difference (debate: opposer)?
Professional & Legal Issues in Cancer Nursing, Walsall, 24 April 2002
Chemoradiotherapy - is there evidence of a radiation dose response?
Chemoradiation: From the Laboratory to the Clinic, Joint Leeds/Royal College of Radiologists Conference, York, 23 November 2000
Preoperative chemoradiotherapy for esophageal cancer: evidence of dose response.
American Society of Clinical Oncology Annual Meeting (poster discussion session), New Orleans, May 2000
Preoperative chemoradiotherapy in oesophageal cancer: is there a dose response?
Combined Chemotherapy & Radiotherapy in GI Tumours, British Institute of Radiology, London, 8 October 1999
Preoperative chemoradiotherapy for locally advanced rectal cancer.
British Oncological Association Annual Meeting (Young Investigator Award), Nottingham, 7 July 1998